ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-DOPA Decarboxylase / DDC Antibody (A283143)

This product is discontinued

Anti-DOPA Decarboxylase / DDC Antibody (A283143) has been discontinued and is no longer available.

View all available products.

Name
Anti-DOPA Decarboxylase / DDC Antibody
Description
Rabbit polyclonal antibody to DOPA Decarboxylase / DDC.
Specificity
This antibody recognises DOPA decarboxylase, also known as aromatic-L-amino acid decarboxylase or DDC), an enzyme that catalyses the decarboxylation of L-3,4-dihydroxyphenylalanine (DOPA) to dopamine, L-5-hydroxytryptophan to serotonin and L-tryptophan to tryptamine. The enzyme is expressed ubiquitously and is essential for the formation of catecholamines, indoleamines and trace amines. DDC is considered to be the rate-limiting step for the formation of trace amines, but not for the formation of catecholamines or indoleamines. It also becomes rate-limiting for dopamine formation in Parkinson's disease patients treated with L-DOPA.
Applications
WB
Dilutions
WB: 1:1,000
Reactivity
Bovine, Rat
Immunogen
SDS denatured, recombinant bovine DOPA decarboxylase expressed E. coli and purified from inclusion bodies.
Host
Rabbit
Clonality
Polyclonal
Isotype
IgG
Conjugate

Unconjugated

Concentration
Lot Specific
Molecular Weight
Approximately 55 kDa in rat adrenal medulla.
Product Form
Liquid
Formulation
Supplied in 10mM HEPES, pH 7.5, with 150mM NaCl, 0.01% BSA, 50% Glycerol, and 0.05% Sodium Azide.
Storage
Shipped at ambient temperature. Upon delivery aliquot and store at -20°C. When thawed, aliquot the sample as needed. Short term (up to 4 weeks): store at 4°C. Long term: store at -20°C. Avoid freeze / thaw cycles. Storage in frost free freezers is not recommended.
General Notes
Rabbit anti Bovine DOPA decarboxylase antibody recognizes DOPA decarboxylase, also known as aromatic-L-amino acid decarboxylase or DDC), an enzyme that catalyses the decarboxylation of L-3,4-dihydroxyphenylalanine (DOPA) to dopamine, L-5-hydroxytryptophan to serotonin and L-tryptophan to tryptamine. The enzyme is expressed ubiquitously and is essential for the formation of catecholamines, indoleamines and trace amines. DDC is considered to be the rate-limiting step for the formation of trace amines, but not for the formation of catecholamines or indoleamines. It also becomes rate-limiting for dopamine formation in Parkinson's disease patients treated with L-DOPA.
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.